| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.22 | 7e-06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.2 | 6e-05 |